HER2/neu (ERBB2) Gene Amplification, FISH, Urothelial Carcinoma
Vitamin D deficiency
HER2/neu (ERBB2), IHC, Semi-Quantitative, Other Tissue
CDH1 Gene Mutation Analysis
Troponin-I/T, Cardiac
Biopsy, Frozen Section
Basic Metabolic Panel (BMP)
CBb Complement Activation Fragment, Plasma
Phenobarbital, Serum
Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
Overview
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now